No Data
No Data
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket
Channel Therapeutics Corporation Announces Name Change Reflecting Focus on Non-Opioid Pain Therapeutics
Chromocell Announces Name Change to "Channel Therapeutics Corporation" and Provides Therapeutic Program Updates
Chromocell Therapeutics | 10-Q: Q3 2024 Earnings Report
Chromocell Unveils Its Injectable Depot Program Utilizing Peripheral Nerve Blocks For The Treatment Of Post-Operative Pain
Express News | Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain